Levosimendan: A Cardiovascular Drug to Prevent Liver Ischemia-Reperfusion Injury?

• Peter Onody ,

  Contributed equally to this work with: Peter Onody, Rita Stangl

  * E-mail: peter.onody@gmail.com

  Affiliation 1st Department of Surgery, Semmelweis University, Budapest, Hungary

  ⨯
• Rita Stangl ,

  Contributed equally to this work with: Peter Onody, Rita Stangl

  Affiliation 1st Department of Surgery, Semmelweis University, Budapest, Hungary

  ⨯
• Andras Fulop,

  Affiliation 1st Department of Surgery, Semmelweis University, Budapest, Hungary

  ⨯
• Oliver Rosero,

  Affiliation 1st Department of Surgery, Semmelweis University, Budapest, Hungary

  ⨯
• David Garbaisz,

  Affiliation 1st Department of Surgery, Semmelweis University, Budapest, Hungary

  ⨯
• Zsolt Turoczi,

  Affiliation 1st Department of Surgery, Semmelweis University, Budapest, Hungary

  ⨯
• Gabor Lotz,

  Affiliation 2nd Department of Pathology, Semmelweis University, Budapest, Hungary

  ⨯
• Zoltan Rakonczay Jr,

  Affiliation First Department of Medicine, University of Szeged, Szeged, Hungary

  ⨯
• Zsolt Balla,

  Affiliation First Department of Medicine, University of Szeged, Szeged, Hungary

  ⨯
• Viktor Hegedus,

  Affiliation 1st Department of Surgery, Semmelweis University, Budapest, Hungary

  ⨯
• Laszlo Harsanyi,

  Affiliation 1st Department of Surgery, Semmelweis University, Budapest, Hungary

  ⨯
• Attila Szijarto

  Affiliation 1st Department of Surgery, Semmelweis University, Budapest, Hungary

  ⨯